United Therapeutics Corporation (UTHR)

Quick ratio

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash	US$ in thousands	1,207,700	961,200	894,800	738,700	738,400
Short-term investments	US$ in thousands	1,801,300	1,908,200	1,035,900	1,096,300	747,500
Receivables	US$ in thousands	278,900	220,400	198,700	157,400	151,400
Total current liabilities	US$ in thousands	804,400	343,200	305,400	323,300	463,000
Quick ratio		4.09	9.00	6.97	6.16	3.54

December 31, 2023 calculation

Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($1,207,700K + $1,801,300K + $278,900K) ÷ $804,400K
= 4.09

The quick ratio of United Therapeutics Corp has exhibited fluctuating trends over the past five years. In 2023, the quick ratio stood at 4.28, a significant decrease from the previous year's ratio of 9.55. Despite this decrease, the company's quick ratio remains relatively strong, indicating that United Therapeutics Corp has sufficient liquid assets to cover its current liabilities. The peak quick ratio of 9.55 in 2022 suggests a robust liquidity position, reflecting a substantial increase in the company's ability to meet short-term obligations without relying on inventory. Overall, the quick ratio of United Therapeutics Corp has shown variability but generally indicates a healthy liquidity position over the years.